PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1391985
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1391985
The global endoprosthesis market size is expected to reach US$ 37.77 Bn by 2030, from US$ 22.80 Bn in 2023, at a CAGR of 7.5% during the forecast period.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 22.80 Bn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 7.50% | 2030 Value Projection: | US$ 37.77 Bn |
Endoprosthesis refers to medical devices that are implanted inside the human body to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure. The global endoprosthesis market has been witnessing steady growth due to the rising incidence of degenerative diseases, trauma cases, and joint disorders. Furthermore, growing geriatric population which are more prone to such conditions has also contributed to the increasing demand for endoprosthesis. However, the high cost of these devices and post-surgery complications like infections have restricted their adoption to some extent. Ongoing technological advancements to develop more biocompatible materials and custom-made solutions according to patient needs are expected to boost the endoprosthesis market during the forecast period.
The global endoprosthesis market is expected to experience significant growth in the coming years, driven by several factors. One of the key drivers is the increasing prevalence of chronic diseases such as osteoarthritis, cardiovascular diseases, and urological disorders. These conditions often require the use of endoprosthesis devices for treatment and management, leading to a higher demand for these products.
Advancements in medical technology are also contributing to the growth of the market. The development of innovative materials and manufacturing techniques has led to the production of more durable and biocompatible endoprosthesis devices. This has improved the success rates of surgeries and enhanced patient outcomes, driving the adoption of these devices.
Moreover, market players are indulged in conducting inorganic activities such as acquisition and this is expected to increase the growth of the global endoprosthesis market over the forecast period. For instance, in 2019, Exactech, a developer and producer of implants, instrumentation, and computer-assisted technologies, acquired its independent distribution partner, Exactech Italia, creating a new corporate subsidiary. The acquisition has increased the customer base for Exactech in over 35 countries globally.
However, there are certain restraints that may hinder the growth of the market. The high cost of endoprosthesis devices and the associated surgical procedures can be a barrier for some patients, especially in developing countries with limited healthcare resources. Additionally, the stringent regulatory requirements for the approval of these devices can pose challenges for manufacturers, leading to delays in product launches.
Despite these challenges, there are several opportunities in the market that can be capitalized on. The growing aging population is expected to drive the demand for endoprosthesis devices as age-related conditions such as joint degeneration and cardiovascular diseases become more prevalent. Additionally, the increasing focus on minimally invasive surgeries and the development of personalized medicine are creating new avenues for growth in the market.